Taken together, these in vitro and in vivo findings suggest that IGF-1R may play a significant role in the development, progression, and metastasis of HCC, and that IGF-1R inhibition may possess the therapeutic value for HCC. Here, IGF1R is linked to hepatocellular carcinoma.